150 related articles for article (PubMed ID: 20462842)
1. Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.
Díaz R; Moral P; Fonfría M; de Juan M; Mancheño N; Tormo A
Clin Transl Oncol; 2010 Apr; 12(4):306-9. PubMed ID: 20462842
[TBL] [Abstract][Full Text] [Related]
2. Primary Maligant Melanoma of the Oesophagus.
Rathi PM; Gautam S; Sharma S
J Assoc Physicians India; 2015 Dec; 63(12):74-75. PubMed ID: 27666909
[TBL] [Abstract][Full Text] [Related]
3. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
[TBL] [Abstract][Full Text] [Related]
5. Primary malignant melanoma of the esophagus associated with adenocarcinoma of the lung.
Yano M; Shiozaki H; Murata A; Inoue M; Tamura S; Taniguchi M; Monden M
Surg Today; 1998; 28(4):405-8. PubMed ID: 9590706
[TBL] [Abstract][Full Text] [Related]
6. A second primary esophageal cancer developing 7 years after chemoradiotherapy for advanced esophageal cancer.
Suto R; Enjoji A; Okudaira S; Furui J; Matsuo T; Kanematsu T
J Gastroenterol; 2001 Jul; 36(7):495-9. PubMed ID: 11480795
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
9. Primary malignant melanoma of the esophagus: report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy.
Naomoto Y; Perdomo JA; Kamikawa Y; Haisa M; Yamatsuji T; Kenzo A; Taguchi K; Hara K; Tanaka N
Jpn J Clin Oncol; 1998 Dec; 28(12):758-61. PubMed ID: 9879295
[TBL] [Abstract][Full Text] [Related]
10. Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides.
Ueda Y; Shimizu K; Itoh T; Fuji N; Naito K; Shiozaki A; Yamamoto Y; Shimizu T; Iwamoto A; Tamai H; Yamagishi H
Jpn J Clin Oncol; 2007 Feb; 37(2):140-5. PubMed ID: 17255158
[TBL] [Abstract][Full Text] [Related]
11. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
12. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent malignant melanoma of esophagus responsive to combined chemotherapy, radiotherapy and cellular immunotherapy].
Motoyama S; Maruyama K; Sato Y; Shibuya K; Usami S; Yoshino K; Nakatsu T; Nanjo H; Kamata S; Ogawa J
Gan To Kagaku Ryoho; 2011 Apr; 38(4):639-42. PubMed ID: 21498995
[TBL] [Abstract][Full Text] [Related]
15. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
[TBL] [Abstract][Full Text] [Related]
16. Primary malignant melanoma of the pharynx.
Oztürk O; Ozek H; Cansiz H; Karakullukçu B
J Laryngol Otol; 2001 Nov; 115(11):931-4. PubMed ID: 11779316
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant melanoma of the oesophagus.
Gul YA; Prasannan S; Hairuszah I
Acta Chir Belg; 2003 Aug; 103(4):420-2. PubMed ID: 14524166
[TBL] [Abstract][Full Text] [Related]
18. [Primary malignant melanoma of the vagina--case report and review of the literature].
Betschart C; von Orelli S; Mihic D; Fink D
Gynakol Geburtshilfliche Rundsch; 2007; 47(1):39-44. PubMed ID: 17272935
[TBL] [Abstract][Full Text] [Related]
19. [Anorectal malignant melanomas. Apropos of 5 cases. Review of the literature].
Melhouf MM; el Amrani N; Mathieu-Daude H; Dubois JB
Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):209-12. PubMed ID: 7486817
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
